HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group.

Abstract
A retrospective study was conducted among Italian children treated with hematopoietic stem cell transplant (HSCT) to evaluate the incidence and risk factors in the development of osteochondroma (OC). OC occurred in 27 patients who received autologous or allogeneic HSCT. The estimated 5-, 10-, and 15-year cumulative risk of developing OC was 0.5%, 3.2%, and 6.1%, respectively. Analysis of cumulative risk stratified by the various risk factors revealed that male sex (P=.026), autologous HSCT (P=.001), age at HSCT (< or =3 years) (P < .0001), and total body irradiation (TBI) (P <.0001) significantly affected the risk of OC. Multivariate analysis, restricted only to tumor types with at least 1 case of OC, showed that earlier age at HSCT (P =.0004) and TBI (P < .0001) were the only factors that were significantly associated with OC.
AuthorsMaura Faraci, Francesca Bagnasco, Paola Corti, Chiara Messina, Franca Fagioli, Marta Podda, Arcangelo Prete, Desirè Caselli, Edoardo Lanino, Giorgio Dini, Roberto Rondelli, Riccardo Haupt, AIEOP-HSCT Group
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 15 Issue 10 Pg. 1271-6 (Oct 2009) ISSN: 1523-6536 [Electronic] United States
PMID19747635 (Publication Type: Journal Article, Multicenter Study)
Topics
  • Adolescent
  • Age Factors
  • Anemia, Aplastic (epidemiology, therapy)
  • Child
  • Child, Preschool
  • Female
  • Genetic Diseases, Inborn
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Infant
  • Italy
  • Male
  • Neoplasms (epidemiology, therapy)
  • Neoplasms, Second Primary (epidemiology)
  • Osteochondroma (epidemiology)
  • Registries
  • Retrospective Studies
  • Risk Factors
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: